Evidence map›Paper›PMID 31443221›Full record

ArticleMicromachines2019

A Lab-on-a-Chip Device Integrated DNA Extraction and Solid Phase PCR Array for the Genotyping of High-Risk HPV in Clinical Samples.

Cancan Zhu, Anzhong Hu, Junsheng Cui, Ke Yang, Xinchao Zhu, Yong Liu, Guoqing Deng, Ling Zhu

Open access · goldAbstract read
In one paragraph

Article in Micromachines, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Cancan ZhuInstitute of Applied Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, 2221 Changjiang Road, Hefei 230000, China.
Anzhong HuInstitute of Applied Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, 2221 Changjiang Road, Hefei 230000, China.
Junsheng CuiInstitute of Applied Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, 2221 Changjiang Road, Hefei 230000, China.
Ke YangInstitute of Applied Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, 2221 Changjiang Road, Hefei 230000, China.
Xinchao ZhuInstitute of Applied Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, 2221 Changjiang Road, Hefei 230000, China.
Yong LiuInstitute of Applied Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, 2221 Changjiang Road, Hefei 230000, China.
Guoqing DengInstitute of Applied Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, 2221 Changjiang Road, Hefei 230000, China.
Ling ZhuInstitute of Applied Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, 2221 Changjiang Road, Hefei 230000, China. zhul@aiofm.ac.cn.
Chinese Academy of Sciences · CNHefei Institutes of Physical Science · CNInstitute of Applied Technology · CN

Funding

Dean's Fund of Hefei Institute of Physical Science, China YZJJ2018QN22Key Research and Development Program of Anhui Province of China 1804a09020051Key Research and Development Program of Anhui Province of China 1804c04020335Key Research Program of the Chinese Academy of Sciences KGFZD-135-18-019Program of the Science and Technology Service Network Initiative KFJ-STS-2018Youth Innovation Promotion Association, Chinese Academy of Sciences 2018489
6 · The paper itself

Abstract

Point-of-care (POC) molecular diagnostics play a crucial role in the prevention and treatment of infectious diseases. It is necessary to develop portable, easy-to-use, inexpensive and rapid molecular diagnostic tools. In this study, we proposed a lab-on-a-chip device that integrated DNA extraction, solid-phase PCR and genotyping detection. The ingenious design of the pneumatic microvalves enabled the fluid mixing and reagent storage to be organically combined, significantly reducing the size of the chip. The solid oligonucleotide array incorporated into the chip allowed the spatial separation of the primers and minimized undesirable interactions in multiplex amplification. As a proof-of-concept for POC molecular diagnostics on the device, five genotypes of high-risk human papillomavirus (HPV) (HPV16/HPV18/HPV31/HPV33/HPV58) were examined. Positive quality control samples and HPV patient cervical swab specimens were analyzed on the integrated microdevice. The platform was capable of detection approximately 50 copies of HPV virus per reaction during a single step, including DNA extraction, solid-phase PCR and genotype detection, in 1 h from samples being added to the chip. This simple and inexpensive microdevice provided great utility for the screening and monitoring of HPV genotypes. The sample-to-result platform will pave the way for wider application of POC molecular testing in the fields of clinical diagnostics, food safety, and environmental monitoring.

Indexed as

high-risk HPV genotypesLab-on-a-chip devicemolecular diagnosisPOC

Identifiers

PMID31443221
PMCPMC6722547
OpenAlexW2967349153

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.